Stroke of DNA

Amy E Baek1

  • 1Science Signaling, AAAS, Washington, DC 20005, USA.

Science Signaling
|August 20, 2024
PubMed

Insights

Circulating cell-free DNA activates the inflammasome, a key immune pathway. This activation is linked to recurrent stroke in patients with atherosclerosis.

Area of Science:

  • Immunology
  • Neurology
  • Cardiovascular Science

Background:

  • Atherosclerosis is a major risk factor for recurrent stroke.
  • Inflammasome activation plays a role in inflammatory diseases.
  • The role of circulating DNA in stroke pathogenesis is not fully understood.

Purpose of the Study:

  • To investigate the link between circulating DNA, inflammasome activation, and recurrent stroke in atherosclerosis patients.

Main Methods:

  • Assessed levels of circulating cell-free DNA (cfDNA) in patients.
  • Measured inflammasome activation markers.
  • Correlated cfDNA levels and inflammasome activity with stroke recurrence.

Main Results:

  • Elevated cfDNA levels were found in patients with recurrent stroke.
  • Higher inflammasome activation correlated with increased cfDNA.
  • cfDNA-driven inflammasome activation was associated with a higher risk of recurrent stroke.

Conclusions:

  • Circulating DNA is a potential driver of inflammasome activation.
  • This pathway contributes to recurrent stroke in atherosclerosis.
  • Targeting cfDNA or inflammasome could offer new therapeutic strategies.